Summary
Target Corporation's (TGT) third-quarter 2015 results show a net sales increase to $17.6 billion, up 2.1% year-over-year, driven by a 1.9% increase in comparable sales and a notable 20% surge in digital channel sales. The company's strategic focus on its digital presence is yielding positive results, contributing significantly to overall comparable sales growth. Profitability saw a mixed picture: GAAP diluted EPS from continuing operations was $0.76, down from $0.82 in the prior year, but adjusted diluted EPS from continuing operations rose to $0.86 from $0.79, reflecting the exclusion of one-time charges. The company continued its commitment to returning capital to shareholders, repurchasing $2.2 billion in stock and paying $1 billion in dividends year-to-date. Significant operational shifts are underway, including the pending divestiture of the pharmacy and clinic businesses to CVS for approximately $1.9 billion, which is expected to generate a substantial pretax gain and contribute positively to future earnings and ROIC. Concurrently, Target is actively managing the wind-down of its Canadian operations, which has resulted in significant charges and adjustments to discontinued operations but is progressing towards resolution. The company also reported ongoing efforts to manage costs and improve efficiency through restructuring initiatives, alongside progress in resolving data breach-related liabilities.
Financial Highlights
47 data points| Revenue | $17.61B |
| Cost of Revenue | $12.44B |
| Gross Profit | $5.17B |
| SG&A Expenses | $3.74B |
| Operating Income | $962.00M |
| Interest Expense | $151.00M |
| Net Income | $549.00M |
| EPS (Basic) | $0.88 |
| EPS (Diluted) | $0.87 |
| Shares Outstanding (Basic) | 623.70M |
| Shares Outstanding (Diluted) | 628.80M |
Key Highlights
- 1Third-quarter sales increased by 2.1% to $17.6 billion, with comparable sales growing by 1.9%.
- 2Digital channel sales experienced robust growth of 20%, contributing positively to overall comparable sales.
- 3Adjusted diluted EPS from continuing operations increased by 8.6% to $0.86, indicating underlying operational strength.
- 4The company is undertaking a significant strategic move with the planned sale of its pharmacy and clinic businesses to CVS for approximately $1.9 billion.
- 5Target returned $1.3 billion to shareholders in the third quarter through dividends and share repurchases, and $5.3 billion year-to-date under an expanded $10 billion share repurchase program.
- 6The company is actively managing the exit from its Canadian operations, with ongoing charges and adjustments to discontinued operations.
- 7Restructuring initiatives are underway to improve organizational effectiveness and achieve cost savings.